Brain and Neuroimaging Devices Market Report 2025

This Brain and Neuroimaging Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The brain and neuroimaging devices market size has grown strongly in recent years. It will grow from $40.65 billion in 2024 to $43.03 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to diagnosis and treatment of neurological disorders, aging population, brain mapping and connectivity research, emerging markets growth.

The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $54.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to regulatory support, personalized medicine, targeted therapies, value-based healthcare. Major trends in the forecast period include high-resolution imaging, multimodal imaging, wearable neuroimaging, connectivity and functional imaging.

The rising prevalence of neurological disorders is anticipated to boost the market. As per a report from the European Academy of Neurology, one out of every three people was affected by a neurological disease in 2022. Furthermore, the number of deaths attributed to neurological disorders has surged by nearly 40% over the past three decades. Brain and neuroimaging devices play a crucial role in the diagnosis and management of these disorders, ultimately contributing to increased survival rates. This escalating incidence of neurological diseases is poised to drive the brain and neuroimaging devices market.

The increasing incidence of traumatic brain injuries (TBI) is expected to drive the growth of brain and neuroimaging devices in the future. TBI refers to brain damage caused by a sudden external force or trauma, which impacts an individual's physical, cognitive, emotional, and behavioral functioning. Brain and neuroimaging devices play a crucial role in diagnosing, assessing, and managing TBI, helping healthcare providers detect issues such as bleeding, fractures, or structural abnormalities. For example, in October 2023, Neural Regeneration Research, a China-based peer-reviewed journal focusing on neuroscience, reported that around 69 million people worldwide suffer from traumatic brain injuries annually. As a result, the rising prevalence of TBI is fueling the growth of the brain and neuroimaging device market.

Companies and researchers are dedicated to creating portable brain scanners, aiming to transform brain imaging by reducing device costs and ensuring accessibility for all. EMVision Medical Devices, in collaboration with researchers at Queensland University, has introduced a portable brain scanning technology. This innovation allows brain scans to be conducted in various locations, expanding imaging possibilities. Similarly, researchers at University College London have developed a lightweight portable MEG brain scanner that resembles a helmet. This device can capture brain activity even during natural movements, offering enhanced imaging capabilities for patients affected by conditions that cause involuntary body movements, such as epilepsy.

Major companies in the brain and neuroimaging device market are actively involved in developing technology integrated with artificial intelligence (AI), exemplified by the Neuro Suite, aimed at achieving a competitive advantage. The Neuro Suite, incorporating artificial intelligence, is specifically engineered to provide extensive solutions as a brain and neuroimaging device for addressing neurological disorders. For instance, in April 2023, TeraRecon, Inc., a US-based company specializing in medical imaging equipment, introduced the Neuro Suite. This innovative solution leverages artificial intelligence to assist in clinical diagnostics for various neurology diseases such as neuro-oncology, multiple sclerosis, and dementia. It enables radiologists to access a range of artificial intelligence-powered neuroimaging modalities.

Major companies operating in the brain and neuroimaging devices market include GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, Medtronic Plc., EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Varian Medical Systems, Toshiba Corporation, Shimadzu Corporation, Agilent Technologies Inc., Waters Corporation, Bruker Corporation, PerkinElmer Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Hologic Inc., Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Intranerve Neuroscience Holdings LLC., Nuvasive Inc., SpecialtyCare Inc.

Brain and neuroimaging devices are medical tools designed to capture the structure, function, or pharmacology of the brain and identify areas impacted by neurological disorders. These devices are utilized to examine cognitive functions and diagnose neurological conditions.

The primary types of brain and neuroimaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is an imaging technique that gauges cellular metabolic activity in body tissues using radioactive elements. These devices have varied applications in conditions such as Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and are extensively utilized in hospitals, diagnostic centers, and ambulatory surgical centers.

The brain and neuroimaging devices market research report is one of a series of new reports that provides brain and neuroimaging devices market statistics, including brain and neuroimaging devices industry global market size, regional shares, competitors with a brain and neuroimaging devices market share, detailed brain and neuroimaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain and neuroimaging devices industry. This brain and neuroimaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Western Europe was the largest region in the brain and neuroimaging devices market in 2024. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the brain and neuroimaging devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.